Loading news...
RadNet, Inc. (RDNT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
RadNet combines a scaled outpatient imaging platform with DeepHealth. This is their AI-enabled radiology software segment that adds growth optionality. RDNT's core imaging demand also remains strong, helped by outpatient site-of-care trends, but their acquisitions and hospital joint ventures are part of the story. Management reported record Q4 2025 revenue, while underlying organic growth suggests the base imaging business is still healthy.
RadNet, Inc. (RDNT) GLEAMER SAS - M&A Call Transcript
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, reminds investors that on Thursday, March 5, 2026, investors are invited to join a dedicated conference call and presentation to hear more details about the recently completed acquisition of Gleamer SAS and RadNet's Digital Health strategy. On the call, investors will also have the opportunity to ask questions of executive management.
/PRNewswire/ -- USANewsGroup.com News Commentary - AI is making its way through the halls of our entire medical system, and the implementation is accelerating
Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gain strong traction. Cidara Therapeutics' shares rose further following Merck's acquisition of the company in a $9.2 billion all-cash deal announced in November 2025, representing a premium of more than 100% over the prior closing price. Doximity's stock detracted from performance as the company issued disappointing guidance for the next two quarters.
RadNet, Inc. (RDNT) Q4 2025 Earnings Call Transcript
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida on, Tuesday, March 3, 2026 at 2:15 p.m. Eastern Time.
RadNet (RDNT) saw its shares rise significantly after posting robust Q4 earnings and revenue growth. The company reported a 14.8% year-over-year increase in rev
While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
RadNet (RDNT) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 418 owned and/or operated outpatient imaging centers, today reported financial results for its fourth quarter and full-year ended December 31, 2025.
DeepHealth's TechLive remote scanning solution achieves CE marking for Europe, accelerated commercial traction in the U.S. and AWS Marketplace availability
Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Daxor (NASDAQ: DXR - Get Free Report) and RadNet (NASDAQ: RDNT - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Volatility and Risk Daxor has a beta of 0.01, indicating
LOS ANGELES, Feb. 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its fourth quarter 2025 financial results on Monday, March 2, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today that it has acquired the outpatient imaging assets of Northwest Radiology Network, P.C., marking the company's entry into Indiana and expanding RadNet's presence into the Midwestern United States.
WCM Investment Management LLC lifted its position in RadNet, Inc. (NASDAQ: RDNT) by 32.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 285,778 shares of the medical research company's stock after acquiring an additional 70,244 shares during the period. WCM Investment Management LLC
New York State Common Retirement Fund decreased its stake in RadNet, Inc. (NASDAQ: RDNT) by 5.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 247,479 shares of the medical research company's stock after selling 13,532 shares during the quarter.
/PRNewswire/ -- USANewsGroup.com News Commentary - The global medical imaging market hit a massive $45.5 billion in 2026[1], marking a total structural shift